Tigecycline population pharmacokinetics in patients with community- or hospital-acquired pneumonia
- PMID: 20921315
- PMCID: PMC2981274
- DOI: 10.1128/AAC.01414-09
Tigecycline population pharmacokinetics in patients with community- or hospital-acquired pneumonia
Abstract
Tigecycline is a new-generation of tetracycline (glycylcyclines) and is active in vitro against bacteria that possess any of the classical genes that confer tetracycline resistance through ribosomal protection or efflux pumps. Herein, tigecycline disposition in patients with community- or hospital-acquired pneumonia was described using a population pharmacokinetic model. Additionally, the influence of covariates, such as body surface area, severity of illness, and clinical laboratory measures, on tigecycline disposition was evaluated. An intravenous loading dose of 100 mg was followed by 50 mg of tigecycline every 12 h. The final population pharmacokinetic model was a two-compartment model with linear elimination and with a relationship between tigecycline clearance and body surface area and creatinine clearance. The model was parameterized using total clearance (CL), the volume of the central compartment, distributional clearance from the central to the peripheral compartment, and volumes of distribution at steady state. Relationships between body surface area and creatinine clearance were identified as significant predictors of interindividual variability on CL. This model will serve as the basis for estimating tigecycline exposure for pharmacokinetic-pharmacodynamic analyses for efficacy and safety among patients with community- or hospital-acquired pneumonia.
Figures


References
-
- Akaike, H. 1979. A Bayesian extension of the minimum AIC procedure of autoregressive model fitting. Biometrika 66:237-242.
-
- Ambrose, P. G., S. M. Bhavnani, C. M. Rubino, A. Louie, T. Gumbo, A. Forrest, and G. L. Drusano. 2007. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: It's not just for mice anymore. Clin. Infect. Dis. 44:79-86. - PubMed
-
- Bassett, E. J., M. S. Keith, G. J. Armelagos, D. L. Martin, and A. R. Villnueva. 1980. Tetracycline labeled human bone from ancient Sudanese Nubia. Science 209:1532-1534. - PubMed
-
- Bauer, R. J. 2006. S-ADAPT/MCPEM user's guide: software for pharmacokinetic, pharmacodynamic and population data analysis. Biomedical Simulations Resource, Los Angeles, CA. http://bmsr.usc.edu/Software/ADAPT/SADAPTsoftware.html.
-
- Beal, S. 2001. Ways to fit a PK model with some data below the quantification limit. J. Pharmacokinet. Pharmacodyn. 2:481-504. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical